198 related articles for article (PubMed ID: 1963345)
1. Neural grafts and pharmacological intervention in a model of Huntington's disease.
Giordano M; Ford LM; Shipley MT; Sanberg PR
Brain Res Bull; 1990 Sep; 25(3):453-65. PubMed ID: 1963345
[TBL] [Abstract][Full Text] [Related]
2. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
[TBL] [Abstract][Full Text] [Related]
3. Female rats are more sensitive to the locomotor alterations following quinolinic acid-induced striatal lesions: effects of striatal transplants.
Emerich DF; Zubricki EM; Shipley MT; Norman AB; Sanberg PR
Exp Neurol; 1991 Mar; 111(3):369-78. PubMed ID: 1847880
[TBL] [Abstract][Full Text] [Related]
4. Embryonic striatal grafts restore neuronal activity of the globus pallidus in a rodent model of Huntington's disease.
Nakao N; Ogura M; Nakai K; Itakura T
Neuroscience; 1999 Jan; 88(2):469-77. PubMed ID: 10197767
[TBL] [Abstract][Full Text] [Related]
5. Fetal striatal transplants restore electrophysiological sensitivity to dopamine in the lesioned striatum of rats with experimental Huntington's disease.
Chen GJ; Jeng CH; Lin SZ; Tsai SH; Wang Y; Chiang YH
J Biomed Sci; 2002; 9(4):303-10. PubMed ID: 12145527
[TBL] [Abstract][Full Text] [Related]
6. Intraparenchymal striatal transplants required for maintenance of behavioral recovery in an animal model of Huntington's disease.
Sanberg PR; Giòrdano M; Henault MA; Nash DR; Ragozzino ME; Hagenmeyer-Houser SH
J Neural Transplant; 1989; 1(1):23-31. PubMed ID: 2535266
[TBL] [Abstract][Full Text] [Related]
7. NADPH-diaphorase-containing neurons and cytochrome oxidase activity following striatal quinolinic acid lesions and fetal striatal transplants.
Sanberg PR; Zubrycki EM; Ragozzino ME; Lu SY; Norman AB; Shipley MT
Prog Brain Res; 1990; 82():427-31. PubMed ID: 1963225
[No Abstract] [Full Text] [Related]
8. DARPP-32-rich zones in grafts of lateral ganglionic eminence govern the extent of functional recovery in skilled paw reaching in an animal model of Huntington's disease.
Nakao N; Grasbon-Frodl EM; Widner H; Brundin P
Neuroscience; 1996 Oct; 74(4):959-70. PubMed ID: 8895865
[TBL] [Abstract][Full Text] [Related]
9. Comparative behavioral and neurochemical studies with striatal kainic acid- or quinolinic acid-lesioned rats.
Vécsei L; Beal MF
Pharmacol Biochem Behav; 1991 Jun; 39(2):473-8. PubMed ID: 1719569
[TBL] [Abstract][Full Text] [Related]
10. Failure of neuroprotection by embryonic striatal grafts in a double lesion rat model of striatonigral degeneration (multiple system atrophy).
Puschban Z; Waldner R; Seppi K; Stefanova N; Humpel C; Scherfler C; Levivier M; Poewe W; Wenning GK
Exp Neurol; 2000 Jul; 164(1):166-75. PubMed ID: 10877927
[TBL] [Abstract][Full Text] [Related]
11. MK801 prevents quinolinic acid-induced behavioral deficits and neurotoxicity in the striatum.
Giordano M; Ford LM; Brauckmann JL; Norman AB; Sanberg PR
Brain Res Bull; 1990 Mar; 24(3):313-9. PubMed ID: 2159831
[TBL] [Abstract][Full Text] [Related]
12. [Protective effect of intrastriatal grafts in an experimental model of Huntington's disease. Behavioral and morphological correlation].
Levivier M; Pearlman SH; Gash DM; Brotchi J
Neurochirurgie; 1991; 37(3):148-59. PubMed ID: 1831884
[TBL] [Abstract][Full Text] [Related]
13. Donor age dependent graft development and recovery in a rat model of Huntington's disease: histological and behavioral analysis.
Schackel S; Pauly MC; Piroth T; Nikkhah G; Döbrössy MD
Behav Brain Res; 2013 Nov; 256():56-63. PubMed ID: 23916743
[TBL] [Abstract][Full Text] [Related]
14. Long-term cortical atrophy after excitotoxic striatal lesion: effects of intrastriatal fetal-striatum grafts and implications for Huntington disease.
Muñoz A; Lopez A; Caruncho HJ; Guerra MJ; Labandeira-García JL
J Neuropathol Exp Neurol; 2001 Aug; 60(8):786-97. PubMed ID: 11487053
[TBL] [Abstract][Full Text] [Related]
15. Behavioral/neurophysiological investigation of effects of combining a quinolinic acid entopeduncular lesion with a fetal mesencephalic tissue transplant in striatum of the 6-OHDA hemilesioned rat.
Olds ME; Jacques DB; Kpoyov O
Synapse; 2003 Jul; 49(1):1-11. PubMed ID: 12710010
[TBL] [Abstract][Full Text] [Related]
16. Striatal implants of fetal striatum or gelfoam protect against quinolinic acid lesions of the striatum.
Pearlman S; Levivier M; Gash DM
Brain Res; 1993 Jun; 613(2):203-11. PubMed ID: 8186968
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine hydroxylase-positive fibers and neurons in transplanted striatal tissue in rats with quinolinic acid lesions of the striatum.
Sanberg PR; Zubrycki E; Ragozzino ME; Giordano M; Shipley MT
Brain Res Bull; 1990 Dec; 25(6):889-94. PubMed ID: 1981175
[TBL] [Abstract][Full Text] [Related]
18. Embryonic donor age and dissection influences striatal graft development and functional integration in a rodent model of Huntington's disease.
Watts C; Brasted PJ; Dunnett SB
Exp Neurol; 2000 May; 163(1):85-97. PubMed ID: 10785447
[TBL] [Abstract][Full Text] [Related]
19. Effects of severity of host striatal damage on the morphological development of intrastriatal transplants in a rodent model of Huntington's disease: implications for timing of surgical intervention.
Watts C; Dunnett SB
J Neurosurg; 1998 Aug; 89(2):267-74. PubMed ID: 9688122
[TBL] [Abstract][Full Text] [Related]
20. Time course of the neuroprotective effect of transplantation on quinolinic acid-induced lesions of the striatum.
Levivier M; Gash DM; Przedborski S
Neuroscience; 1995 Nov; 69(1):43-50. PubMed ID: 8637631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
